Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
glaxosmithkline
4
×
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
boston blog main
boston top stories
deals
national top stories
new york blog main
new york top stories
san francisco top stories
startups
abbvie
alzheimer's disease
bausch health
biogen
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
diagnostics
dihydroergotamine
drug prices
gene therapy
generic drugs
gilead sciences
immunotherapy
indiana blog main
indiana top stories
kaiser family foundation
medicare
merck
migraine
multiple myeloma
What
drug
4
×
bio
companies
earlier
new
pfizer
roundup
acquisitions
activity
adds
albert
alliance
approval
areas
biggest
biogen’s
biopharmaceutical
biosciences
biotech
bio’s
bourla
brii
ceo
company
convo
crispr
days
disease
dog
failures
firm
future
hasn’t
hepatitis
imports
infectious
ipo
ipos
launched
leading
Language
unknown
unset
Current search:
glaxosmithkline
×
drug
×
biotech
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline